Literature DB >> 23238630

Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?

Emad A Rakha1, Carolien H M van Deurzen, E Claire Paish, R Douglas Macmillan, Ian O Ellis, Andrew H S Lee.   

Abstract

Pleomorphic lobular carcinoma is regarded as a biologically aggressive variant of invasive lobular carcinoma of the breast. However, there is no consensus on the definition and whether this subtype adds useful information to histological grade. Two-hundred and two grade 2 or grade 3 invasive lobular carcinomas were studied. Tumours were categorised according to the components of histological grade: tubules, pleomorphism and mitoses. Pleomorphic lobular carcinoma was defined as a carcinoma with a lobular growth pattern and marked nuclear pleomorphism (pleomorphism 3). Breast cancer-specific survival was used in analysis of prognosis. Grade 3 pleomorphic lobular carcinomas (tubules 3, pleomorphism 3, mitoses 2 and tubules 3, pleomorphism 3, mitoses 3) had a worse prognosis than grade 2 (tubules 3, pleomorphism 2, mitoses 1) carcinomas. Grade 2 lobular carcinomas with marked nuclear pleomorphism (tubules 3, pleomorphism 3, mitoses 1) had a similar prognosis to grade 2 carcinomas with moderate pleomorphism (tubules 3, pleomorphism 2, mitoses 1). Survival was associated with mitotic score, but not with nuclear pleomorphism on both univariate and multivariate analysis. A non-classical growth pattern was seen more frequently in all subgroups with marked nuclear pleomorphism and was associated with worse survival. Histological grade and nodal status were independent of prognostic factors. This study shows that histological grade (in particular the mitotic component) in invasive lobular carcinomas is of prognostic importance, but pleomorphic type does not provide useful additional prognostic information.

Entities:  

Mesh:

Year:  2012        PMID: 23238630     DOI: 10.1038/modpathol.2012.197

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

Review 1.  Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.

Authors:  Nikhil Pramod; Akanksha Nigam; Mustafa Basree; Resham Mawalkar; Saba Mehra; Neelam Shinde; Gary Tozbikian; Nicole Williams; Sarmila Majumder; Bhuvaneswari Ramaswamy
Journal:  Oncologist       Date:  2021-03-16

2.  Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.

Authors:  Yu Zhang; Xiulan Luo; Min Chen; Libo Yang; Ting Lei; Tianjie Pu; Bing Wei; Hong Bu; Zhang Zhang
Journal:  Breast Cancer Res Treat       Date:  2022-06-06       Impact factor: 4.872

3.  Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.

Authors:  Rita A Mukhtar; Gregor Krings; Yunn-Yi Chen; Matina E Mamounas; Kelly Fahrner-Scott; Jasmine Wong; Michael Alvarado; Cheryl Ewing; Laura J Esserman; Hope Rugo
Journal:  Breast Cancer Res Treat       Date:  2020-04-02       Impact factor: 4.872

4.  Molecular classification of breast cancer.

Authors:  Darina Vuong; Peter T Simpson; Benjamin Green; Margaret C Cummings; Sunil R Lakhani
Journal:  Virchows Arch       Date:  2014-05-31       Impact factor: 4.064

Review 5.  Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.

Authors:  Amy E McCart Reed; Jamie R Kutasovic; Sunil R Lakhani; Peter T Simpson
Journal:  Breast Cancer Res       Date:  2015-01-30       Impact factor: 6.466

6.  Clinicopathological characteristics and survival outcomes in pleomorphic lobular breast carcinoma of the breast: a SEER population-based study.

Authors:  Li-Peng Yang; He-Fen Sun; Yang Zhao; Meng-Ting Chen; Nong Zhang; Wei Jin
Journal:  Cancer Med       Date:  2017-11-13       Impact factor: 4.452

7.  Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort.

Authors:  A Mukherjee; E Provenzano; R Russell; Suet-Feung Chin; B Liu; O M Rueda; H R Ali; G Turashvili; B Mahler-Araujo; I O Ellis; S Aparicio; C Caldas
Journal:  NPJ Breast Cancer       Date:  2018-03-07

8.  Assessment of Digital Pathology Imaging Biomarkers Associated with Breast Cancer Histologic Grade.

Authors:  Andrew Lagree; Audrey Shiner; Marie Angeli Alera; Lauren Fleshner; Ethan Law; Brianna Law; Fang-I Lu; David Dodington; Sonal Gandhi; Elzbieta A Slodkowska; Alex Shenfield; Katarzyna J Jerzak; Ali Sadeghi-Naini; William T Tran
Journal:  Curr Oncol       Date:  2021-10-27       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.